Renal Disease and Atrial Fibrillation

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Atrial fibrillation (AF) and chronic kidney disease (CKD) are increasingly prevalent conditions.
• The coexistence of AF and CKD presents complex challenges in patient management.
• Renal impairment exacerbates stroke risk in AF patients but also increases bleeding propensity.

Purpose of the Study:

• To review the interplay between AF and CKD.
• To discuss the implications for anticoagulation therapy in patients with coexisting conditions.
• To provide guidance on monitoring renal function and selecting appropriate anticoagulants.

Main Methods:

• Literature review of studies investigating AF, CKD, and anticoagulation.
• Analysis of risk factors for thromboembolism and bleeding in renal impairment.
• Evaluation of anticoagulation strategies, including direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs).

Main Results:

• Renal impairment significantly increases the risk of ischemic stroke and systemic thromboembolism in AF patients.
• Paradoxically, renal dysfunction also predisposes patients to bleeding events.
• DOACs require careful consideration regarding renal function.
• Dose-adjusted VKAs can be used in mild to moderate renal dysfunction.
• Dialysis-dependent patients on VKAs face a heightened risk of major hemorrhage.

Conclusions:

• Close monitoring of renal function is essential for AF patients on anticoagulation.
• Anticoagulation strategies must be tailored to individual renal function.
• Particular caution is advised for dialysis-dependent patients, especially those on VKAs.